Browsing: drug development
Generative biology, the use of AI to design molecules and program biological functions, has moved from laboratory promise into clinical…
Even before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite.The Cambridge, Mass.-based biotech priced its…
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs…
Senators Welch (D-VT), Cortez Masto (D-NV) and Wyden (D-OR) introduced legislation last month to repeal a provision in the One…
We are on a bureaucratic trajectory where American leadership in approving innovative medicines may not be sustainable and our most…
With the U.S. election in the rearview mirror, we have arrived at a defining moment for the future of medical…
Pharmaceutical clinical trials present both a compelling and challenging use case for Artificial Intelligence. Look at one aspect of trials…